Metalloproteinase

Metalloproteinase is a type of enzyme that plays a crucial role in the degradation of extracellular matrix proteins. These enzymes are part of the larger family of proteases, which are responsible for breaking down proteins and peptides. Metalloproteinases are unique in that they require a metal ion for their activity, hence the name.

Structure and Function

Metalloproteinases are characterized by their dependence on metal ions, most commonly zinc, for their catalytic activity. They have a highly conserved protein structure, with a characteristic "metzincin" fold that allows for the binding of the metal ion.

The primary function of metalloproteinases is the degradation of the extracellular matrix, a complex network of proteins and polysaccharides that provides structural and biochemical support to cells. This process is essential for numerous biological processes, including cell migration, tissue remodeling, and wound healing.

Types of Metalloproteinases

There are several types of metalloproteinases, each with specific substrates and functions. These include:

• Matrix metalloproteinases (MMPs): These enzymes are responsible for the degradation of most extracellular matrix proteins. They play a crucial role in many physiological processes, such as embryogenesis, normal tissue remodeling, and wound healing.

• ADAM (A Disintegrin And Metalloproteinase) and ADAMTS (ADAM with Thrombospondin Motifs): These enzymes have additional domains that allow them to interact with specific substrates. They are involved in the processing of growth factors and cytokines.

• Astacins: This family of metalloproteinases is found in bacteria, fungi, and animals. They are involved in a variety of biological processes, including digestion, development, and immune response.

Clinical Significance

Abnormal activity of metalloproteinases has been implicated in a number of diseases, including cancer, arthritis, cardiovascular diseases, and neurodegenerative diseases. As such, these enzymes are potential targets for therapeutic intervention. Several inhibitors of metalloproteinases have been developed, some of which are currently in clinical trials.

See Also

• Protease
• Enzyme
• Extracellular matrix
• Zinc

• 
  PDB 1af0 EBI